» Articles » PMID: 36969190

Tissue-resident Memory T Cells in Gastrointestinal Tumors: Turning Immune Desert into Immune Oasis

Overview
Journal Front Immunol
Date 2023 Mar 27
PMID 36969190
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue-resident memory T cells (Trm) are a particular type of T cell subgroup, which stably reside in tissues and have been revealed to be the most abundant memory T cell population in various tissues. They can be activated in the local microenvironment by infection or tumor cells and rapidly clean them up to restore homeostasis of local immunity in gastrointestinal tissues. Emerging evidence has shown that tissue-resident memory T cells have great potential to be mucosal guardians against gastrointestinal tumors. Therefore, they are considered potential immune markers for immunotherapy of gastrointestinal tumors and potential extraction objects for cell therapy with essential prospects in clinical translational therapy. This paper systematically reviews the role of tissue-resident memory T cells in gastrointestinal tumors and looks to the future of their prospect in immunotherapy to provide a reference for clinical application.

Citing Articles

CD69CD103CD8 tissue-resident memory T cells possess stronger anti-tumor activity and predict better prognosis in colorectal cancer.

Wu Z, Da T, Huang C, Wang X, Li L, Zhao Z Cell Commun Signal. 2024; 22(1):608.

PMID: 39696312 PMC: 11657194. DOI: 10.1186/s12964-024-01990-3.


Advances in the diagnosis and treatment of MET-variant digestive tract tumors.

Zhang C, Dong H, Gao J, Zeng Q, Qiu J, Wang J World J Gastrointest Oncol. 2024; 16(11):4338-4353.

PMID: 39554732 PMC: 11551650. DOI: 10.4251/wjgo.v16.i11.4338.


Tissue-Resident Memory T Cells in Gastrointestinal Cancers: Prognostic Significance and Therapeutic Implications.

Sato H, Meng S, Hara T, Tsuji Y, Arao Y, Sasaki K Biomedicines. 2024; 12(6).

PMID: 38927549 PMC: 11202222. DOI: 10.3390/biomedicines12061342.


Down-regulated HHLA2 enhances neoadjuvant immunotherapy efficacy in patients with non-small cell lung cancer (NSCLC) with chronic obstructive pulmonary disease (COPD).

Zeng A, Yin Y, Xu Z, Abuduwayiti A, Yang F, Shaik M BMC Cancer. 2024; 24(1):396.

PMID: 38553708 PMC: 10979619. DOI: 10.1186/s12885-024-12137-5.

References
1.
Baeyens A, Bracero S, Chaluvadi V, Khodadadi-Jamayran A, Cammer M, Schwab S . Monocyte-derived S1P in the lymph node regulates immune responses. Nature. 2021; 592(7853):290-295. PMC: 8475585. DOI: 10.1038/s41586-021-03227-6. View

2.
Schenkel J, Masopust D . Tissue-resident memory T cells. Immunity. 2014; 41(6):886-97. PMC: 4276131. DOI: 10.1016/j.immuni.2014.12.007. View

3.
Besser M, Shapira-Frommer R, Treves A, Zippel D, Itzhaki O, Hershkovitz L . Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients. Clin Cancer Res. 2010; 16(9):2646-55. DOI: 10.1158/1078-0432.CCR-10-0041. View

4.
Mattei F, Andreone S, Marone G, Gambardella A, Loffredo S, Varricchi G . Eosinophils in the Tumor Microenvironment. Adv Exp Med Biol. 2020; 1273:1-28. DOI: 10.1007/978-3-030-49270-0_1. View

5.
Okla K, Farber D, Zou W . Tissue-resident memory T cells in tumor immunity and immunotherapy. J Exp Med. 2021; 218(4). PMC: 7992502. DOI: 10.1084/jem.20201605. View